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1. Introduction 
The enzyme 2',3'-cyclic nucleotide 3'-phosphodi- 
esterase (CNPase, EC 3.1.4.37) hydrolyzes the 3'-phos- 
phodiester bond of 2',3'-cyclic phosphodiester nucle- 
otides to produce the 2'-monophosphate nucleotides 
exclusively. The 2',3'-cyclic nucleotides are known to 
occur as intermediates during enzymatic degradation 
of RNA. Evidence for this conclusion has been based 
on experiments carried out with purified RNAase prep- 
arations from various ources, in which 2',3'-cyclic 
nucleotides, as well as terminal 2',3'-cyclic phospho- 
diesters of oligonucleotides, are formed as products 
during short periods of RNAase action on RNA [1 ]. 
CNPase activity has been found in a variety of 
mammalian tissues and cells such as brain [2], spleen 
[3], pancreas [4], intestinal mucosa [2], as well as in 
fibroblasts [5], and red blood cells [6]. This enzyme 
activity has also been found in bacteria [7]. However, 
CNPase activity is most prominent in membranes of
the central nervous ystem (CNS) [2] and shows a 
remarkably high activity in myelin [8], a tissue frac- 
tion in which only a few enzymes are present in 
readily measurable quantities. Developmental changes 
in CNPase activity have been shown to correlate well 
with myelination patterns in chick brain and spinal 
cord [9] and parts of rat brain [10]. Due to the close 
association of CNPase to myelin, CNS white matter 
has preferentially been used for CNPase preparations 
[11-13]. Several attempts have been made to purify 
and characterize brain CNPase. However, the molecu- 
lar weights reported are rather inconsistent, ranging 
from 30 000 to 100 000 [11,13-17]. The molecular 
structure of this prominent brain enzyme, therefore, 
is still unclear. 
In the present study we describe molecular weight 
determinations performed by three different methods 
using purified brain CNPase. Based on these analyses 
we have identified two active enzyme forms which 
provide strong evidence for a model proposed here of 
polypeptide composition of brain CNPase. 
2. Materials and methods 
2',3'-Cyclic nicotinamide-adenine dinucleotide 
phosphate (2',3'-cNADP), bovine serum albumin 
(BSA), and egg albumin were purchased from Sigma 
Chemical Co. (St Louis). 2',3'-Cyclic nucleotide 
adenosine monophosphate (2',3 '-cAMP), 2',3 '-cGMP, 
2',3'-cUMP, and 2',3'-cCMP were obtained from 
Boehringer (Mannheim). The tritium labelled nucle- 
otides 8-[3H] 2',3'-cAMP and 2',3'-cGMP were synthe- 
sized by Amersham Buchler (Braunschweig). Acryl- 
amide, bisacrylamide, ammonium persulfate, sodium 
dodecyl sulfate, Coomassie Brilliant Blue R-250, 
cytochrome c, and ferritin were obtained from Serva 
(Heidelberg). Human gamma globulin was produced 
by Miles Laboratories (Elkhart). All other chemicals 
used in these studies were of analytical grade purchased 
from Merck (Darmstadt). 
Isolation of CNPase from bovine brain white matter 
was accomplished by guanidinium hydrochloride 
extraction and carboxymethyl Sephadex column chro- 
matography using established procedures [12,18]. The 
specific activity of this preparation was 2500 U/mg 
protein, representing a 250-fold purification of the 
enzyme from white matter (specific activity approx. 
10 U/rag protein). 
CNPase activity was routinely assayed in 50 mM 
sodium acetate buffer, pH 5.5, containing 1mg/ml 
BSA and 0.1% (v/v) NP40, by the conversion of 2',3'- 
cyclic NADP to the 2'-phosphodiester (2'-NADP) 
according to the method of Sogin [19]. One unit of 
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CNPase is defined as the amount of enzyme that pro- 
duces 1/1tool of 2'-NADP per min at 37°C. 
For the analysis of substrate specificity of CNPase, 
various 2',3'-cyclic nucleoside monophosphates, a  
well as cNADP, were tested (cAMP, cGMP, cCMP, 
cUMP). The amount of conversion of substrate to 
product was estimated spectrophotometrically [11 ]. 
In the cases of 2',3'-cAMP and 2',3 '-cGMP the activity 
was verified using radioactively abelled precursors 
[10], in which case substrate and product nucleotides 
were separated by thin layer chromatography. 
Protein concentration was measured using a protein 
assay according to Bradford [20]. 
Sodium dodecyl sulfate (SDS) gel electrophoresis 
was carried out on calibrated 12% (w/v) polyacrylamide 
gels under reducing conditions according to Laemmli 
[21 ]. Prior to electrophoresis the protein samples 
were boiled for 2 min at 100°C in the presence of 2% 
(w/v) SDS and 5% (v/v) 2-mercaptoethanol. Protein 
bands were detected by staining of the gels with 
Coomassie Brilliant Blue, and the molecular weights 
were estimated using BSA (68 000), ferritin (50 000), 
carbonic anhydrase (29 000), and cytochrome c 
(12 300) as standards. 
Gel filtration of CNPase was carried out at 4°C on 
a Sepharose 6B column (2.5 × 90 cm), equilibrated 
with 50 mM 2-(N-morpholino) ethane sulfonic acid- 
NaOH (MES-NaOH) buffer, pH 6.0, containing 
150 mM NaC1, and 5% (v/v) glycerol. Human gamma 
globulin (150 000), BSA (68 000), egg albumin 
(45 000) and cytochrome c (12 000) were used as 
molecular weight standards. 
Sedimentation rate analyses were performed by 
centrifugation of CNPase in linear 32 ml sucrose 
density gradients (10-35%, w/v). All gradients were 
prepared in 50 mM MES-NaOH buffer, pH 6.2, con- 
taining 1 mM of each EDTA and dithiothreitol and 
centrifuged for 15 h at 150 000 × gay in a titanium 
vertical rotor using a Beckman ODT 2 ultracentrifuge. 
One-ml fractions were collected. Molecular weight 
estimations were based on co-centrifugation f the 
protein standards used in gel Filtration except hat egg 
albumin was replaced by carbonic anhydrase (29 000). 
3. Results and discussion 
In accordance with other studies on substrate spe- 
cificity of CNPase [2,6] our preparation hydrolyzes 
the various 2',3'-cyclic nucleotides in the following 
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Fig.1. SDS-polyacrylamide gel electrophoresis of bovine brain 
CNPase. 40 ~g of enzyme protein were prepared and run as 
described insection 2 (K = kilodalton). 
order (specific activities are given in brackets): cNADP 
(2500 U/mg) > cAMP (1450 U/mg) > cGMP 
(900 U/mg) > cCMP (320 U/mg) > cUMP (160 U/mg). 
The K m values of our CNPase preparation have been 
determined to be 5.5 - 10 -4 M and 3.7 • 10-4 M for 
cNADP and cAMP, respectively. 
In SDS-polyacrylamide g lelectrophoresis (rigA) 
freshly isolated CNPase migrated as a polypeptide 
double band with the apparent Mr values of 54 000 + 
1000 and 51 000 -+ 1000, respectively. During storage 
of the enzyme at 4°C, low M r breakdown products of 
the protein double band may appear (not shown). 
When the molecular weight of CNPase was deter- 
mined under native conditions using Sepharose 6B 
gel filtration (fig.2), the enzyme activity was eluted at 
a volume (210 ml) corresponding tom r 120 000 -+ 
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Fig.2. Elution profile of brain CNPase (1.0 mg protein) from 
Sephaxose 6B column. The void volume (Vo) as well as the 
elution volume of marker proteins are indicated. 
10 000 (high molecular weight enzyme form), agreeing 
rather well with a previous estimation of about 100 000 
using a similar procedure [11 ]. 
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Fig.3. Sucrose density gradient centrifugation f brain CNPase 
in the absence ofBSA (upper profile, 500 ~g enzyme protein), 
or in the presence ofBSA (lower profile, 50 ~zg enzyme pro- 
rein). The position of marker protein peaks axe indicated. 
Further details are given in section 2. 
Sedimentation rate analyses of CNPase in linear 
sucrose density gradients were performed in the 
absence or presence of BSA (10 mg/ml) in the enzyme 
sample loaded on top of the gradient. When BSA was 
omitted the main peak of CNPase activity (fig.3, 
upper profile) corresponded toM r 50 000 -+ 8000 
(low molecular weight enzyme form). This result is in 
good agreement with the estimations for CNPase poly- 
peptides (51-54 000) in SDS-polyacrylamide g l
electrophoresis (fig.l). However, in presence of BSA 
the activity peak of CNPase appeared near the bottom 
of the gradient tube corresponding to a higher M r of 
approx. 100 000 -+ 8000 (fig.3, lower profile), which 
agrees well with the high molecular weight form 
obtained by gel filtration (fig.2). Minor shoulders of 
activity appearing in the lower tool. wt range of both 
gradients may represent partial degradation of the 
enzyme protein. 
The high mol. wt enzyme form of approx. 100 000 
(fig.3b) not only occurs in sucrose gradient analysis 
containing BSA (M r 68 000), but also appears when 
the same analysis is carried out in the presence of 
other proteins of varyingM r values, e.g. human gamma 
globulin (150 000), carbonic anhydrase (29 000), or 
myelin basic protein (18 000) (unpublished). It is 
unlikely that the high mol. wt enzyme form represents 
an aggregate between aCNPase polypeptide and any 
of the added proteins, since the apparent molecular 
weights of these corresponding complexes would not 
coincide with M r of 100 000. It is also noteworthy 
that the heavy enzyme form found during gel filtra- 
tion was obtained in the absence of additional protein. 
The persistence ofthe high mol. wt form of CNPase 
during gel f'fltration as well as in sedimentation rate 
analysis in the presence of BSA or other proteins makes 
it likely that CNPase has an M r of about 100 000. 
This heavy enzyme form could be interpreted as being 
composed of two polypeptide chains with the apparent 
M r values of 51 000 and 54 000 as separated by SDS- 
gel electrophoresis (fig.1) representing anM r of approx. 
105 000. The appearance o fanM r 50 000 peak of 
activity in sucrose density gradient analysis without 
BSA may indicate that the active site of the enzyme 
is associated with one (or both) of the dissociated 
polypeptide bands. The aggregate of two such subunits 
may be disrupted uring sucrose density gradient cen- 
trifugation unless protected by additional protein. 
Possibly due to a deviation from the spherical shape, 
the mol. wt of the heavy enzyme form may be some- 
what overestimated during gel filtration (M r 120 000) 
39 
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when compared with the sum of the molecular weight 
of the two polypeptides found in SDS gels. Assuming 
anM r of about 100 000 for brain CNPase the molecu- 
lar activity (turnover numbers) o four enzyme prepara- 
tion for the hydrolysis of 2',3'-cyclic nucleotides can 
be calculated from the appropriate specific activities 
given above. The apparent turnover numbers for 
cNADP, cAMP, cGMP, cCMP and cUMP are 25.0 • 104, 
14.5 • 104 , 9.0 - 104 , 3.2 • 104 and 1.6 • 104 , respec- 
tively. 
For several reasons a comparison of some bio- 
chemical properties between the two types of enzymes 
CNPase and RNAase is of particular interest: 
(a) CNPase fractionates very closely with RNAase 
activities in preparations from bovine spleen and liver 
[22] and the RNAase preparation from liver might be 
associated with a CNPase inhibitor [23]. 
(b) Both enzyme activities hydrolyze 2',3'-cyclic 
nucleotide phosphodiesters, the known intermediates 
of RNA degradation [1,22]. However, unlike CNPase, 
the RNAase activities liberate the 3'-phosphomonoester 
from these cyclic nucleotides [1 ]. The K m values 
estimated for pancreatic RNAase A are 6.9 - 10 -3 M 
(cUMP) and 3.5 - 10 -3 M (cCMP). For brain RNAase 
neither K m values nor turnover numbers for the hydro- 
lysis of 2',3'-cyclic nucleotides have so far been 
reported. However, there is evidence for the existence 
of RNAases in brain, which hydrolyze RNA only to 
2',3'-cyclic nucleotides [25}. 
(c) Two catalytically active enzyme forms (mono- 
meric and dimeric structures) have earlier been reported 
also for RNAases from different sources [26-28]. 
The physiological role of brain CNPase has not yet 
been elucidated, but there is some evidence for the 
possibility that this enzyme might be involved in the 
degradative or salvage pathway of RNA metabolism. 
It has been calculated [29] that CNS has a rapid turn- 
over of RNA compared e.g. with liver. On the other 
hand, the functional role of the remarkably high 
CNPase activity in myelin fractions from CNS is still 
an open question. 
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